MicroRNA-21 deficiency suppresses prostate cancer progression through downregulation of the IRS1-SREBP-1 signaling pathway
Thanigaivelan Kanagasabai(Meharry Medical College), Zhenbang Chen(University of Georgia), Zaniya A. Mark(Meharry Medical College), Renjie Jin(Vanderbilt University Medical Center), Samuel E. Adunyah(Meharry Medical College), LaKendria K. Brown(Meharry Medical College), Nataliya Gladoun(Columbia University Irving Medical Center), Yingqiu Xie(Nazarbayev University), Carlos Cordon‐Cardo(Icahn School of Medicine at Mount Sinai), Billy R. Ballard(Meharry Medical College), Mireia Castillo-Martín(Champalimaud Foundation), Robert J. Matusik(Vanderbilt University Medical Center), Sherly I. Celada(Meharry Medical College), Guoliang Li(Xi'an University of Science and Technology), Tian Shen(Columbia University Irving Medical Center), Josiah Ochieng(Meharry Medical College)
Cited by 57
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
A multigenic program mediating breast cancer metastasis to bone
|Cancer Cell|2003|2.6k
Acid Sphingomyelinase–Deficient Human Lymphoblasts and Mice Are Defective in Radiation-Induced Apoptosis
|Cell|1996|797
The Mechanisms of PML-Nuclear Body Formation
|Molecular Cell|2006|517
Lipopolysaccharide Induces Disseminated Endothelial Apoptosis Requiring Ceramide Generation
|The Journal of Experimental Medicine|1997|406